Alana Harris Dent

Array ( [id] => 9273330 [patent_doc_number] => 08637260 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Phosphorylated RaIA' [patent_app_type] => utility [patent_app_number] => 13/108951 [patent_app_country] => US [patent_app_date] => 2011-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 54 [patent_no_of_words] => 18887 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13108951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586352 [patent_doc_number] => 20110280862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'GEP AND DRUG TRANSPORTER REGULATION, CANCER THERAPY AND PROGNOSIS' [patent_app_type] => utility [patent_app_number] => 13/107034 [patent_app_country] => US [patent_app_date] => 2011-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 7051 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280862.pdf [firstpage_image] =>[orig_patent_app_number] => 13107034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7573113 [patent_doc_number] => 20110268769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'DRUG DELIVERY VEHICLE FOR CANCER THERAPY, PROCESS FOR PRODUCING THE SAME, AND PHARMACEUTICAL PREPARATION USING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/103275 [patent_app_country] => US [patent_app_date] => 2011-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10088 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20110268769.pdf [firstpage_image] =>[orig_patent_app_number] => 13103275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5935743 [patent_doc_number] => 20110212023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'TADG-15: an extracellular serine protease overexpossed in carcinomas' [patent_app_type] => utility [patent_app_number] => 13/068264 [patent_app_country] => US [patent_app_date] => 2011-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 14427 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212023.pdf [firstpage_image] =>[orig_patent_app_number] => 13068264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8209017 [patent_doc_number] => 20120128677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'PANCREATIC CANCER TARGETS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/100902 [patent_app_country] => US [patent_app_date] => 2011-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 43580 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20120128677.pdf [firstpage_image] =>[orig_patent_app_number] => 13100902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5938555 [patent_doc_number] => 20110213337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'Methods for the early diagnosis of ovarian cancer' [patent_app_type] => utility [patent_app_number] => 13/066897 [patent_app_country] => US [patent_app_date] => 2011-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 15270 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20110213337.pdf [firstpage_image] =>[orig_patent_app_number] => 13066897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10381931 [patent_doc_number] => 20150266938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-24 [patent_title] => 'MODULATION OF MUC1 ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/094624 [patent_app_country] => US [patent_app_date] => 2011-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 24367 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13094624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7766032 [patent_doc_number] => 20120034159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'ANTIBODIES THAT BIND BOTH BCMA AND TACI' [patent_app_type] => utility [patent_app_number] => 13/089899 [patent_app_country] => US [patent_app_date] => 2011-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 22831 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20120034159.pdf [firstpage_image] =>[orig_patent_app_number] => 13089899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586371 [patent_doc_number] => 20110280881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'NOVEL ANTI-HSP90 MONOCLONAL ANTIBODY' [patent_app_type] => utility [patent_app_number] => 13/086064 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 24849 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280881.pdf [firstpage_image] =>[orig_patent_app_number] => 13086064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6090375 [patent_doc_number] => 20110218150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'ANTIANGIOGENIC POLYPEPTIDES AND METHODS FOR INHIBITING ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 13/069943 [patent_app_country] => US [patent_app_date] => 2011-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10692 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218150.pdf [firstpage_image] =>[orig_patent_app_number] => 13069943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7739503 [patent_doc_number] => 08105596 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'Immunotherapy of B-cell malignancies using anti-CD22 antibodies' [patent_app_type] => utility [patent_app_number] => 13/048223 [patent_app_country] => US [patent_app_date] => 2011-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11018 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/105/08105596.pdf [firstpage_image] =>[orig_patent_app_number] => 13048223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8300993 [patent_doc_number] => 20120183551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'NOVEL HUMAN P53 SPLICE VARIANT DISPLAYING DIFFERENTIAL TRANSCRIPTIONAL ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/040998 [patent_app_country] => US [patent_app_date] => 2011-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13132 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13040998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7499454 [patent_doc_number] => 20110262444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'FORM-SPECIFIC ANTIBODIES FOR NAG-1 (MIC-1, GDF-15), H6D AND OTHER TGF-BETA SUBFAMILY AND HEART DISEASE AND CANCER DIAGNOSES' [patent_app_type] => utility [patent_app_number] => 13/039894 [patent_app_country] => US [patent_app_date] => 2011-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11510 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262444.pdf [firstpage_image] =>[orig_patent_app_number] => 13039894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8257423 [patent_doc_number] => 08206899 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'Prostate cancer-related compositions, methods and kits based on DNA microarray proteomics platforms' [patent_app_type] => utility [patent_app_number] => 13/011792 [patent_app_country] => US [patent_app_date] => 2011-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 50096 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13011792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5969042 [patent_doc_number] => 20110150876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'Prognosis and Treatment of Breast Cancer' [patent_app_type] => utility [patent_app_number] => 13/010258 [patent_app_country] => US [patent_app_date] => 2011-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15910 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20110150876.pdf [firstpage_image] =>[orig_patent_app_number] => 13010258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7742323 [patent_doc_number] => 20120020989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'METHODS OF TREATING COLORECTAL CANCER' [patent_app_type] => utility [patent_app_number] => 13/009193 [patent_app_country] => US [patent_app_date] => 2011-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8786 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20120020989.pdf [firstpage_image] =>[orig_patent_app_number] => 13009193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10123552 [patent_doc_number] => 09157904 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-13 [patent_title] => 'Wnt antagonists and methods of treatment and screening' [patent_app_type] => utility [patent_app_number] => 13/005214 [patent_app_country] => US [patent_app_date] => 2011-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 39245 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13005214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10123552 [patent_doc_number] => 09157904 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-13 [patent_title] => 'Wnt antagonists and methods of treatment and screening' [patent_app_type] => utility [patent_app_number] => 13/005214 [patent_app_country] => US [patent_app_date] => 2011-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 39245 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13005214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054591 [patent_doc_number] => 20110110951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'ISOLATION OF FIVE NOVEL GENES CODING FOR NEW FC RECEOPTRS-TYPE MELANOMA INVOLVED IN THE PATHOGENESIS OF LYMPHOMA/MELANOMA' [patent_app_type] => utility [patent_app_number] => 12/981400 [patent_app_country] => US [patent_app_date] => 2010-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 22260 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110951.pdf [firstpage_image] =>[orig_patent_app_number] => 12981400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6165820 [patent_doc_number] => 20110195499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'UTILITY OF RET MUTANT IN DIAGNOSIS AND TREATMENT OF MELANOMA' [patent_app_type] => utility [patent_app_number] => 12/981466 [patent_app_country] => US [patent_app_date] => 2010-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 9606 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195499.pdf [firstpage_image] =>[orig_patent_app_number] => 12981466 [rel_patent_id] =>[rel_patent_doc_number] =>)